Peter C. Grayson
Impact in
- Rheumatology top 0.2%
- Otitis Media and Relapsing Polychondritis
- Systemic Lupus Erythematosus Research
- Nephrology top 0.5%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Vasculitis and related conditions 73
- Rheumatology 54
- Otitis Media and Relapsing Polychondritis 42
- Systemic Lupus Erythematosus Research 8
- Co-authors
- Peter A. Merkel (56 shared papers)Michael P. LaValley (3 shared papers)Hyon K. Choi (1 shared paper)Seoyoung C. Kim (1 shared paper)Mariana J. Kaplan (9 shared papers)Mark A. Ahlman (23 shared papers)Ravi Suppiah (26 shared papers)Joanna Robson (26 shared papers)
- Journals
- Annals of the Rheumatic Diseases (22 papers)Arthritis & Rheumatology (19 papers)Lara D. Veeken (14 papers)Blood (10 papers)Arthritis Care & Research (9 papers)
- Partner nations
- United StatesUnited KingdomPortugal
In The Last Decade
Peter C. Grayson
142 papers receiving 6.4k citations
Peter C. Grayson's Hit Papers
Peers
Comparison fields: 5 of 126
- Rheumatology 2.1k
- Nephrology 902
- Pulmonary and Respiratory Medicine 3.4k
- Genetics 777
- Immunology 929
Countries citing papers authored by Peter C. Grayson
This map shows the geographic impact of Peter C. Grayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Grayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Grayson more than expected).
Fields of papers citing papers by Peter C. Grayson
This network shows the impact of papers produced by Peter C. Grayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Grayson. The network helps show where Peter C. Grayson may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter C. Grayson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hyperuricemia and incident hypertension: A systematic review and meta‐analysis Hit paper breakdown → | 2010 | 577 |
| 2 | 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis Hit paper breakdown → | 2022 | 273 |
| 3 | 18F‐Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis Hit paper breakdown → | 2017 | 251 |
| 4 | 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis Hit paper breakdown → | 2022 | 243 |
| 5 | 2011 | 243 | |
| 6 | 2001 | 221 | |
| 7 | 2001 | 217 | |
| 8 | 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis Hit paper breakdown → | 2022 | 196 |
| 9 | 2015 | 176 | |
| 10 | 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis Hit paper breakdown → | 2022 | 172 |
| 11 | 2012 | 172 | |
| 12 | Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1 Hit paper breakdown → | 2021 | 149 |
| 13 | Large-vessel vasculitis Hit paper breakdown → | 2022 | 140 |
| 14 | 2018 | 131 | |
| 15 | Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population Hit paper breakdown → | 2023 | 126 |
| 16 | 2013 | 126 | |
| 17 | 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis Hit paper breakdown → | 2022 | 123 |
| 18 | 2014 | 121 | |
| 19 | 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis Hit paper breakdown → | 2022 | 120 |
| 20 | 2015 | 115 |
About Peter C. Grayson
Peter C. Grayson is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Immunology, Genetics and Molecular Biology, having authored 147 papers that have together received 6.5k indexed citations. Recurring topics across this work include Vasculitis and related conditions (73 papers), Otitis Media and Relapsing Polychondritis (42 papers), Vascular Anomalies and Treatments (11 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), Systemic Lupus Erythematosus Research (8 papers), Atherosclerosis and Cardiovascular Diseases (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Inflammasome and immune disorders (6 papers). The work is most often cited by research in Rheumatology (2.1k citations), Nephrology (902 citations), Pulmonary and Respiratory Medicine (3.4k citations), Genetics (777 citations) and Immunology (929 citations). Peter C. Grayson has collaborated with scholars based in United States, United Kingdom and Portugal. Frequent co-authors include Peter A. Merkel, Michael P. LaValley, Hyon K. Choi, Seoyoung C. Kim, Mariana J. Kaplan, Mark A. Ahlman, Ravi Suppiah, Joanna Robson, Raashid Luqmani and Gunnar Tómasson. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Lara D. Veeken, Blood and Arthritis Care & Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.